BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2112726)

  • 1. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis.
    Garibotto G; Acquarone N; Saffioti S; Deferrari G; Villaggio B; Ferrario F
    Nephron; 1989; 51(3):409-12. PubMed ID: 2493141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    Murgo AJ
    Am J Kidney Dis; 1987 Mar; 9(3):241. PubMed ID: 3826074
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW; Michaelson R; Viscuso RL; Winn R; Mulgaonakar S; Jacobs MG
    Arch Intern Med; 1983 Aug; 143(8):1617-8. PubMed ID: 6870446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report.
    Verwey J; Boven E; van der Meulen J; Pinedo HM
    Cancer; 1984 Dec; 54(12):2878-81. PubMed ID: 6437662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
    Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of the hemolytic-uremic syndrome in adults].
    Grabensee B; Passlick J
    Dtsch Med Wochenschr; 1987 Jul; 112(27):1089-91. PubMed ID: 3595471
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    Chow S; Roscoe J; Cattran DC
    Am J Kidney Dis; 1986 May; 7(5):407-12. PubMed ID: 3085480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
    Wils J; Grave W; van Breda Vriesman PJ
    Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 16. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 18. Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
    van Spreeuwel JP; Hemrika MH; de Maat CE; Nadorp JH
    Neth J Med; 1983; 26(9):287-8. PubMed ID: 6419134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
    Acheson DW; Donohue-Rolfe A
    J Clin Oncol; 1989 Dec; 7(12):1943. PubMed ID: 2511278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.